Key facts: The final rebate rule will be a positive change for patients

While drug middlemen are making billions of dollars in record profits at a time when millions of Americans are facing financial struggles, they are also suing to block the final rebate rule, a policy to lower out-of-pocket drug costs for patients. The fact is that the final rebate rule is a good policy for patients – one that policymakers and stakeholders have been carefully considering for years.

Source: The Catalyst - January 19, 2021 Category: Pharmaceuticals Authors: Tom Wilbur Tags: Part D Out-of-Pocket Costs Pharmacy Benefit Managers Source Type: news